Clinical trial
Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
NCT00410371 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00410371 |
|---|---|
| Title | Study to Compare Two Formulations of Lamotrigine in Healthy Subjects |
| Official title | An Open-label, Randomised, Single-dose, Parallel-group Study to Evaluate the Pharmacokinetic Characteristics, Safety and Tolerability of up to Two Formulations (With Different Taste Masking Approaches) of an Orally Disintegrating Tablet (ODT) of Lamotrigine at 25mg and 200mg Versus the Immediate… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Mental Disorders |
| Intervention type | Drug |
| Interventions | Lamotrigine, GI267119 |
| Enrollment | 96 |
| Start date | Dec 28, 2006 |
| Primary completion | Jan 25, 2007 |
| Completion | Jan 25, 2007 |
| First posted | Dec 12, 2006 |
| Last update posted | Sep 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: